DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
Direct targeting of C9ORF72 repeat RNA with fluorinated antisense oligonucleotides
Hexanucleotide repeat expansions in the C9ORF72 gene are the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia. These expansions give rise to pathogenic sense and antisense repeat RNAs that form nuclear foci and undergo repeat-associated non-AUG translation, producing dipeptide repeat proteins with cellular toxicity. Directly targeting the causative repeat RNAs with antisense oligonucleotides represents a promising therapeutic strategy. One barrier to further development is the propensity of this G-rich repeat-containing RNA target to form stable secondary structures, which may hinder efficient hybridization. In this study, we designed a panel of fluorine-modified ASOs that target the sense repeat expansions. We identified C-rich F-ASO gapmers that reduced translation from sense repeat RNAs in a cell-based reporter assay and lowered the RNA foci burden in patient-derived cells. Structural analyses in vitro revealed that the 2'F-RNA gapmer formed a stable hairpin structure. Our results demonstrate that structural properties of fluorine modifications can be leveraged for effective binding of repeat RNA and highlight the potential for F-ASOs to serve as therapeutic tools when targeting toxic repeat RNAs in C9ORF72-mediated FTD/ALS and other repeat expansion diseases., This work was supported by the European Union Marie Skłodowska-Curie Actions (MSCA-IF-799693 to M.G., MSCA-IF-841260 to J.J.-A., and MSCA-IF-750624 to A.G.-M.), the CSIC Internationalization Program IF_ERC, and the Ramón y Cajal Program (RYC2023-043599-I) to M.G.; the National Institutes of Health (1R01GM135646-01) to K.T.G.; the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery Grant #2022-03372 to M.J.D.; and the Spanish “Ministerio de Ciencia e Innovación” (PID2023-146366NB-I00) to C.G. Further funding of this study was provided by the UK Human Functional Genomics Initiative (MR/Y031016/1) and ERA-NET Neuron (Brain4Sight, 01EW2202) and the Carl-Zeiss Stiftung with the “CZS breakthroughs” project entitled “InteReg: Interactive Biomaterials for Neural Regeneration” (P2024-02-015) to B.B. J.J.-A. also acknowledges fellowships from Fundación Alfonso Martín Escudero and Fundación Ramón Areces. H.M.B. and M.J.D. are members of the Centre de recherche en biologie structurale (CRBS), supported by the Fonds de Recherche du Québec – Health Research Centres (Grant #288558), and acknowledge graduate funding from the NSERC CREATE Programmed Molecules for Therapeutics, Sensing, and Diagnostics (PROMOTE). Funding to pay the Open Access publication charges for this article was provided by the Natural Sciences and Engineering Research Council of Canada (NSERC)., Peer reviewed
Proyecto:
EC / H2020 79969
,
EC / H2020 841260
,
EC / H2020 750624
,
CSIC / Internationalization Program IF_ERC
,
AEI / Ramón y Cajal RYC2023-043599-I
,
AEI / Proyectos de Generación de Conocimiento PID2023-146366NB-I00
DOI: http://hdl.handle.net/10261/442809, https://api.elsevier.com/content/abstract/scopus_id/105037057099
HANDLE: http://hdl.handle.net/10261/442809, https://api.elsevier.com/content/abstract/scopus_id/105037057099